Friday, October 09, 2009 2:01:14 AM
Sheff DD Alert #3 on PDMI (.0021) could be a potential buyout from a big ophthalmology medical company as potential is discovered from their products.
"From the 312 bi-manual cases; 51 eyes were selected to perform a new technique using ultrasound emulsification & Laser Phacolysis (Bi-manual-Bi-Energy) simultaneously utilizing two systems: Paradigm's Photon System & Alcon's Legacy McCool or Accurus systems. "
"Conclusion...The Bi-manual-Bi-Energy (BIMBIE)technique can remove literally any kind of cataract through two small paracenthesis, using almost half the energy necessary compared to the traditional KPE techniques, and it is the key that connects the Kelman phacomulsification technique with the phacolysis technique."
This is a groundbreaking approach for surgical techniques and it is using the Alcon system & Paradigm system in combination. That is significant to any big medical company particularly Alcon. Great to see a small upstart like Paradigm mentioned in the same name as a company great like Alcon. Paradigm products have signficant value that big companies are starting to realize.
Per the PR, PMDI appointed a new President, Stephen Davis. He has an excellent track record in the Medical field.
"Mr. Davis brings over 25 years of experience in global healthcare and medical devices markets and over 14 of those in the ophthalmic arena to Paradigm Medical Industries, Inc. Stephen has also served as the President and CEO for Zinetics Medical, Inc. Salt Lake City, Utah for nine years. Stephen was successful in raising over $2.7 million for Zinetics Medical and spearheaded the purchase of Zinetics Medical by Medtronic for over $50 million. He served as Site Director for Medtronic Functional Diagnostics for a year after the conclusion of the sale of Zinetics Medical. Prior to those responsibilities, Stephen was the Western Area Director for Barnes-Hind Hydrocurve and held additional responsibilities as a Regional Vice-President and District Sales Manager. He possesses a stellar background in the areas of strategic planning, start-up ventures, P&L and has a successful record in developing business in preparation for acquisition. Mr. Davis also has an extensive knowledge of the International markets. Stephen has a B.S. from Brigham Young University and additional studies in International Business and Finance."
He served as Site Director for Medtronic Functional Diagnostics for a year after the conclusion of the sale of Zinetics Medical. Prior to those responsibilities, Stephen was the Western Area Director for Barnes-Hind Hydrocurve and held additional responsibilities as a Regional Vice-President and District Sales Manager
He possesses a stellar background in the areas of strategic planning, start-up ventures, P&L and has a successful record in developing business in preparation for acquisition.
"From the 312 bi-manual cases; 51 eyes were selected to perform a new technique using ultrasound emulsification & Laser Phacolysis (Bi-manual-Bi-Energy) simultaneously utilizing two systems: Paradigm's Photon System & Alcon's Legacy McCool or Accurus systems. "
"Conclusion...The Bi-manual-Bi-Energy (BIMBIE)technique can remove literally any kind of cataract through two small paracenthesis, using almost half the energy necessary compared to the traditional KPE techniques, and it is the key that connects the Kelman phacomulsification technique with the phacolysis technique."
This is a groundbreaking approach for surgical techniques and it is using the Alcon system & Paradigm system in combination. That is significant to any big medical company particularly Alcon. Great to see a small upstart like Paradigm mentioned in the same name as a company great like Alcon. Paradigm products have signficant value that big companies are starting to realize.
Per the PR, PMDI appointed a new President, Stephen Davis. He has an excellent track record in the Medical field.
"Mr. Davis brings over 25 years of experience in global healthcare and medical devices markets and over 14 of those in the ophthalmic arena to Paradigm Medical Industries, Inc. Stephen has also served as the President and CEO for Zinetics Medical, Inc. Salt Lake City, Utah for nine years. Stephen was successful in raising over $2.7 million for Zinetics Medical and spearheaded the purchase of Zinetics Medical by Medtronic for over $50 million. He served as Site Director for Medtronic Functional Diagnostics for a year after the conclusion of the sale of Zinetics Medical. Prior to those responsibilities, Stephen was the Western Area Director for Barnes-Hind Hydrocurve and held additional responsibilities as a Regional Vice-President and District Sales Manager. He possesses a stellar background in the areas of strategic planning, start-up ventures, P&L and has a successful record in developing business in preparation for acquisition. Mr. Davis also has an extensive knowledge of the International markets. Stephen has a B.S. from Brigham Young University and additional studies in International Business and Finance."
He served as Site Director for Medtronic Functional Diagnostics for a year after the conclusion of the sale of Zinetics Medical. Prior to those responsibilities, Stephen was the Western Area Director for Barnes-Hind Hydrocurve and held additional responsibilities as a Regional Vice-President and District Sales Manager
He possesses a stellar background in the areas of strategic planning, start-up ventures, P&L and has a successful record in developing business in preparation for acquisition.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
